184 related articles for article (PubMed ID: 16772827)
1. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study.
Addario L; Scaglione G; Tritto G; Di Costanzo GG; De Luca M; Lampasi F; Galeota Lanza A; Picciotto FP; Tartaglione MT; Utech W; Macr M; Giannelli E; Ascione A
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):713-20. PubMed ID: 16772827
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
[TBL] [Abstract][Full Text] [Related]
3. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study.
Botta F; Giannini E; Romagnoli P; Fasoli A; Malfatti F; Chiarbonello B; Testa E; Risso D; Colla G; Testa R
Gut; 2003 Jan; 52(1):134-9. PubMed ID: 12477775
[TBL] [Abstract][Full Text] [Related]
4. [The prognostic value of end-stage liver disease model in liver cirrhosis].
Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
[TBL] [Abstract][Full Text] [Related]
5. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the monoethylglycinexylidide test in alcoholic cirrhosis.
Bhise SB; Dias RJ; Mali KK
Saudi J Gastroenterol; 2007; 13(3):118-23. PubMed ID: 19858627
[TBL] [Abstract][Full Text] [Related]
7. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
8. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
Zipprich A; Kuss O; Rogowski S; Kleber G; Lotterer E; Seufferlein T; Fleig WE; Dollinger MM
Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
[TBL] [Abstract][Full Text] [Related]
10. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
[TBL] [Abstract][Full Text] [Related]
11. Measuring lidocaine metabolite--monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis.
Huang YS; Lee SD; Deng JF; Wu JC; Lu RH; Lin YF; Wang YJ; Lo KJ
J Hepatol; 1993 Aug; 19(1):140-7. PubMed ID: 8301034
[TBL] [Abstract][Full Text] [Related]
12. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
Lindskov J
Acta Med Scand; 1982; 212(5):303-8. PubMed ID: 7180580
[TBL] [Abstract][Full Text] [Related]
13. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis.
Oellerich M; Burdelski M; Lautz HU; Schulz M; Schmidt FW; Herrmann H
Ther Drug Monit; 1990 May; 12(3):219-26. PubMed ID: 2349604
[TBL] [Abstract][Full Text] [Related]
14. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
[TBL] [Abstract][Full Text] [Related]
16. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
17. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
Bhise SB; Dias RJ
Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
[TBL] [Abstract][Full Text] [Related]
18. [Monoethylglycinexylidide--a metabolite of lidocaine--as an index of liver function in chronic hepatic parenchymal diseases].
Kupcová V; Turecký L; Szántová M; Schmidtová K
Bratisl Lek Listy; 1999 Jan; 100(1):12-24. PubMed ID: 10492993
[TBL] [Abstract][Full Text] [Related]
19. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients.
Ecochard M; Boillot O; Guillaud O; Roman S; Adham M; Mion F; Dumortier J
Clin Transplant; 2011; 25(5):755-65. PubMed ID: 21158918
[TBL] [Abstract][Full Text] [Related]
20. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
Hassan EA; Abd El-Rehim AS
Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
